Search
for
Sort by
Research 121–150 of 1000+
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Gefitinib: an adverse effects profile
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Safety of High-Dose Vitamin A
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Hair Growth After Gefitinib Treatment
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Erlotinib induced acneiform eruption: A case report
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- In Fond Memory of Dr. Marla Rosenberg
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- Prevention of erlotinib-induced folliculitis with doxycycline
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Highlights
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Protein Kinase C as a Therapeutic Target
- Rash from EGFR inhibitors: Opportunities and challenges for palliation